Asthma |
Inflammatory disease of the airways characterized by: |
|
• Infiltration by eosinophils, lymphocytes and neutrophils |
|
• Mast cell activation |
|
• Epithelial loss |
|
Associated reversible airway obstruction, recurrent symptoms and bronchial hyper-responsiveness |
|
Gene-by-environment interactions are important |
Inflammation |
Plays central role in asthma pathophysiology |
|
Mediated by T cells, lymphocytes, mast cells, eosinophils and epithelium. Other resident cells such as fibroblasts and smooth muscle play a role |
Airway remodeling |
As inflammation proceeds, other changes evolve leading to reparative or remodeling changes and include: |
|
• Sub-basement membrane thickening |
|
• Subepithelial fibrosis |
|
• Smooth muscle hypertrophy |
|
• Angiogenesis |
|
Mucus gland hyperplasia and hypersecretion |
Bronchoconstriction |
Airway narrowing resulting in wheezing |
|
Probably acutely due to release of mast cell mediators such as histamine, leukotrienes, and tryptase |
|
Obstruction could be mediated by multiple factors: |
|
• Smooth muscle contraction |
|
• Airway edema |
|
• Airway remodeling and fibrosis |
Bronchial Hyperresponsiveness |
Exaggerated bronchoconstrictive response to a wide variety of stimuli; best measured clinically by methacholine challenge testing; mediated by inflammation, remodeling and other airway changes that occur in asthma |